Tofacitinib Citrate CAS 540737-29-9

Khoom Piav Qhia:

Khoom Lub Npe: Tofacitinib citrate CAS TSIS TAU: 540737-29-9

Lub ntsiab lus:

3-((3R, 4R) -4-methyl-3- (methyl (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino) piperidin-1-yl) -3-oxopropanenitrile 2-hydroxypropane- 1,2,3-tricarboxylate;

Tofacitinibcitrate;

2-hydroxypropane-1,2,3-tricarboxylic acid, 3-[(3R, 4R) -4-methyl-3- [methyl (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino] piperidin -1-yl] -3-oxopropanenitrile;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Dawb mus rau beige hmoov

Kev Ntsuas: ≥99.0%

Cov ntsiab lus Melting: 201 ℃ (decomp)

Cia Temp: Chav sov

Solubility: DMSO: soluble5mg/mL (tov meej; sov)

Cov Ntaub Ntawv Kev Nyab Xeeb:

WGK Lub Tebchaws Yelemees: 3

HS Code: 29335990

CP-690550 yog pyrrolo [2,3-d] pyrimidine derivative, raws li Janus kinase inhibitor rau kev kho mob rheumatoid mob caj dab. Torfacitinib citrate tuaj yeem siv ua ke nrog methotrexate rau kev kho mob rheumatoid mob caj dab nrog cov lus teb tsis txaus rau qog necrosis factor inhibitors. Hauv kev soj ntsuam kuaj mob, qhov tshwm sim tsis zoo feem ntau ntawm tofacitinib citrate yog kab mob ua pa kab mob hauv siab, mob taub hau, raws plab, txhaws qhov ntswg, mob caj pas, thiab nasopharyngitis.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: tofacitinib citrate cas 540737-29-9, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: (1R, 5S, 6S) -6- [1 (R) -Hydroxyethyl] -1-methyl-2- [1- (2-thiazolin-2-yl) azetidin-3-ylsulfanyl] -1-carba-2- penem-3-carboxylic Acid Pivaloyloxymethyl Ester CAS 161715-24-8
• Tom ntej: Azilsartan CAS 147403-03-0